Quarterly call:

$25.4m cash

1st patient recruited Nov22, 5 sites activated. Should accelerate now post Christmas shutdowns.

But looking at 2 years before results are available >> 2 years recruitment + 24 weeks trial + assessment of data > 2025

no mid-way readout as would be penalised statistically and so would then need more patients

Pediatric trial can go ahead only if adult P3 trial is a success

Hello!

Thanks to all the former contributors - good reading!

Has anyone tried to model this themselves? What gross margin assumptions are you using / overheads moving forward / rate of penetration. And does anyone know the assumptions behind the $1.6bn TAM?

Thanks